These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29604541)

  • 1. Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives.
    Salado IG; Baán A; Verdeyen T; Matheeussen A; Caljon G; Van der Veken P; Kiekens F; Maes L; Augustyns K
    Eur J Med Chem; 2018 May; 151():18-26. PubMed ID: 29604541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the trypanocidal activity of methyltriazenes in an animal model by the addition of an amidino group.
    Buddhu S; Penketh PG; Divo AA; Shyam K; Patton CL; Sartorelli AC
    Acta Trop; 1991 Apr; 49(1):69-72. PubMed ID: 1678578
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective delivery of 2-hydroxy APA to Trypanosoma brucei using the melamine motif.
    Klee N; Wong PE; Baragaña B; Mazouni FE; Phillips MA; Barrett MP; Gilbert IH
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4364-6. PubMed ID: 20615694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei.
    Cleghorn LA; Albrecht S; Stojanovski L; Simeons FR; Norval S; Kime R; Collie IT; De Rycker M; Campbell L; Hallyburton I; Frearson JA; Wyatt PG; Read KD; Gilbert IH
    J Med Chem; 2015 Oct; 58(19):7695-706. PubMed ID: 26418485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.
    Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
    Eur J Med Chem; 2017 Dec; 141():446-459. PubMed ID: 29049963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis Therapeutics.
    Klug DM; Tschiegg L; Diaz R; Rojas-Barros D; Perez-Moreno G; Ceballos G; García-Hernández R; Martinez-Martinez MS; Manzano P; Ruiz LM; Caffrey CR; Gamarro F; Pacanowska DG; Ferrins L; Navarro M; Pollastri MP
    J Med Chem; 2020 Mar; 63(5):2527-2546. PubMed ID: 31670951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-trypanosomal activity of doubly modified salinomycin derivatives.
    Antoszczak M; Steverding D; Sulik M; Janczak J; Huczyński A
    Eur J Med Chem; 2019 Jul; 173():90-98. PubMed ID: 30986574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis.
    Barker RH; Liu H; Hirth B; Celatka CA; Fitzpatrick R; Xiang Y; Willert EK; Phillips MA; Kaiser M; Bacchi CJ; Rodriguez A; Yarlett N; Klinger JD; Sybertz E
    Antimicrob Agents Chemother; 2009 May; 53(5):2052-8. PubMed ID: 19289530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of purine-nitrile TbcatB inhibitors for use in vivo and evaluation of efficacy in murine models.
    Mallari JP; Zhu F; Lemoff A; Kaiser M; Lu M; Brun R; Guy RK
    Bioorg Med Chem; 2010 Dec; 18(23):8302-9. PubMed ID: 21051236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei.
    Pham T; Walden M; Butler C; Diaz-Gonzalez R; Pérez-Moreno G; Ceballos-Pérez G; Gomez-Pérez V; García-Hernández R; Zecca H; Krakoff E; Kopec B; Ichire O; Mackenzie C; Pitot M; Ruiz LM; Gamarro F; González-Pacanowska D; Navarro M; Dounay AB
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3629-3635. PubMed ID: 28729055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spiroarsoranes of second generation: evaluation of trypanocidal properties against Trypanosoma brucei brucei.
    Loiseau PM; Wolf JG; Gayral P
    Trop Med Parasitol; 1993 Mar; 44(1):32-6. PubMed ID: 8516630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel triazine dimers with potent antitrypanosomal activity.
    Venkatraj M; Salado IG; Heeres J; Joossens J; Lewi PJ; Caljon G; Maes L; Van der Veken P; Augustyns K
    Eur J Med Chem; 2018 Jan; 143():306-319. PubMed ID: 29197735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of selective tubulin inhibitors as anti-trypanosomal agents.
    Bobba V; Nanavaty V; Idippily ND; Zhao A; Li B; Su B
    Bioorg Med Chem; 2017 Jun; 25(12):3215-3222. PubMed ID: 28428042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kola acuminata proanthocyanidins: a class of anti-trypanosomal compounds effective against Trypanosoma brucei.
    Kubata BK; Nagamune K; Murakami N; Merkel P; Kabututu Z; Martin SK; Kalulu TM; Huq M; Yoshida M; Ohnishi-Kameyama M; Kinoshita T; Duszenko M; Urade Y
    Int J Parasitol; 2005 Jan; 35(1):91-103. PubMed ID: 15619520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Trypanosomatid Elemanolide Sesquiterpene Lactones from Vernonia lasiopus O. Hoffm.
    Kimani NM; Matasyoh JC; Kaiser M; Brun R; Schmidt TJ
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28397756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of s-triazine substituted polyamines as potential new anti-trypanosomal drugs.
    Klenke B; Stewart M; Barrett MP; Brun R; Gilbert IH
    J Med Chem; 2001 Oct; 44(21):3440-52. PubMed ID: 11585449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urea Derivatives of 2-Aryl-benzothiazol-5-amines: A New Class of Potential Drugs for Human African Trypanosomiasis.
    Patrick DA; Gillespie JR; McQueen J; Hulverson MA; Ranade RM; Creason SA; Herbst ZM; Gelb MH; Buckner FS; Tidwell RR
    J Med Chem; 2017 Feb; 60(3):957-971. PubMed ID: 27992217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites.
    Baliani A; Bueno GJ; Stewart ML; Yardley V; Brun R; Barrett MP; Gilbert IH
    J Med Chem; 2005 Aug; 48(17):5570-9. PubMed ID: 16107157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.